Cost Of Revenue - Fisher & Paykel Healthcare Corporation Ltd (ASX:FPH) - Alpha Spread
F

Fisher & Paykel Healthcare Corporation Ltd
ASX:FPH

Watchlist Manager
Fisher & Paykel Healthcare Corporation Ltd
ASX:FPH
Watchlist
Price: 34.72 AUD -1.03% Market Closed
Market Cap: 20.3B AUD
Have any thoughts about
Fisher & Paykel Healthcare Corporation Ltd?
Write Note

Fisher & Paykel Healthcare Corporation Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fisher & Paykel Healthcare Corporation Ltd
Cost of Revenue Peer Comparison

Comparables:
T
TRU

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
F
Fisher & Paykel Healthcare Corporation Ltd
ASX:FPH
Cost of Revenue
-NZ$698.4m
CAGR 3-Years
1%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
T
Truscreen Group Ltd
ASX:TRU
Cost of Revenue
-NZ$1.4m
CAGR 3-Years
-25%
CAGR 5-Years
-1%
CAGR 10-Years
N/A

See Also

What is Fisher & Paykel Healthcare Corporation Ltd's Cost of Revenue?
Cost of Revenue
-698.4m NZD

Based on the financial report for Mar 31, 2024, Fisher & Paykel Healthcare Corporation Ltd's Cost of Revenue amounts to -698.4m NZD.

What is Fisher & Paykel Healthcare Corporation Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-15%

Over the last year, the Cost of Revenue growth was -9%. The average annual Cost of Revenue growth rates for Fisher & Paykel Healthcare Corporation Ltd have been 1% over the past three years , -15% over the past five years .

Back to Top